Study Tests Minimally Invasive Treatment for Barrett's Esophagus

Study Tests Minimally Invasive Treatment for Barrett’s Esophagus

Perelman School of Medicine conducted a study of endoluminal therapy, an endoscopy-based treatment, on patients with Barrett’s esophagus or in the early stages of cancer and found that neoplasia was eliminated in 95 percent of patients, according to a Gastrointestinal Endoscopy Journal article.

The retrospective cohort study was conducted with 166 patients and found that endoluminal therapy for patients with Barrett’s esophagus with high grade dysplasia or early cancer was highly successful, but a third of patients experienced a reoccurrence of intestinal metaplasia.

More Articles on Gastroenterology:
Study Evaluates Efficacy of LINX Magnetic Device for Reflux Disease
Four-Day International GI Conference Ends
Review: Resistant Starch Could Help Body Resist Colorectal Cancer

Next Up in GI & Endoscopy

Study Tests Minimally Invasive Treatment for Barrett’s Esophagus

Next Up in GI & Endoscopy

FDA clears final trial stage for robotic GI surgery system

Gastroenterologist pay breakdown in 10 stats

5 GI leaders on what’s changing in colonoscopy

The Value of Integrated AI: Smarter Risk Management for Group Health Carriers

Next Up in GI & Endoscopy

FDA clears final trial stage for robotic GI surgery system

Gastroenterologist pay breakdown in 10 stats

5 GI leaders on what’s changing in colonoscopy

Join the 40,000+ ASC leaders who start their day with Becker's